Correlation Between BioNTech and Tarsus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both BioNTech and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioNTech and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioNTech SE and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on BioNTech and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioNTech with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioNTech and Tarsus Pharmaceuticals.
Diversification Opportunities for BioNTech and Tarsus Pharmaceuticals
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between BioNTech and Tarsus is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding BioNTech SE and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and BioNTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioNTech SE are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of BioNTech i.e., BioNTech and Tarsus Pharmaceuticals go up and down completely randomly.
Pair Corralation between BioNTech and Tarsus Pharmaceuticals
Given the investment horizon of 90 days BioNTech SE is expected to under-perform the Tarsus Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, BioNTech SE is 1.09 times less risky than Tarsus Pharmaceuticals. The stock trades about -0.02 of its potential returns per unit of risk. The Tarsus Pharmaceuticals is currently generating about 0.25 of returns per unit of risk over similar time horizon. If you would invest 3,900 in Tarsus Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of 758.00 from holding Tarsus Pharmaceuticals or generate 19.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 95.65% |
| Values | Daily Returns |
BioNTech SE vs. Tarsus Pharmaceuticals
Performance |
| Timeline |
| BioNTech SE |
| Tarsus Pharmaceuticals |
BioNTech and Tarsus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with BioNTech and Tarsus Pharmaceuticals
The main advantage of trading using opposite BioNTech and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioNTech position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.| BioNTech vs. Novavax | BioNTech vs. Ginkgo Bioworks Holdings | BioNTech vs. Crispr Therapeutics AG | BioNTech vs. Ocean Biomedical |
| Tarsus Pharmaceuticals vs. Aldeyra | Tarsus Pharmaceuticals vs. Travere Therapeutics | Tarsus Pharmaceuticals vs. Eton Pharmaceuticals | Tarsus Pharmaceuticals vs. Connect Biopharma Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |